Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F O'Brien

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Muscle & Nerve. Supplement|January 1, 1997
Injection techniques for botulinum toxin using electromyography and electrical stimulationC F O'Brien
Advances in Neurology|May 12, 2001
Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gaitC F O'Brien
Seminars in Neurology|September 1, 1995
Involuntary movement disorders following lightning and electrical injuriesC F O'Brien
Neurology|June 20, 1998
Extending levodopa action: COMT inhibitionP Martínez-Martín, C F O'Brien
Archives of Neurology|September 1, 1991
N-methyl-D-aspartate antagonists in the treatment of Parkinson's diseaseJ T Greenamyre, C F O'Brien
Muscle & Nerve. Supplement|January 1, 1997
A clinical overview of treatment decisions in the management of spasticityM E Gormley, C F O'Brien, S A Yablon
Drugs & Aging|November 1, 1996
Spasticity after stroke. Epidemiology and optimal treatmentC F O'Brien, L C Seeberger, D B Smith
Neuroscience Letters|October 28, 1991
Heterogeneous dopamine receptor changes in early and late Huntington's diseaseE K Richfield, C F O'Brien, T Eskin, et al.
Neurorehabilitation and Neural Repair|August 31, 2001
The estimated cost of managing focal spasticity: a physician practice patterns surveyP W Radensky, J W Archer, S F Dournaux, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study)D D Truong, P A Cullis, C F O'Brien, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Muscle & Nerve. Supplement|January 1, 1997
Injection techniques for botulinum toxin using electromyography and electrical stimulationC F O'Brien
Advances in Neurology|May 12, 2001
Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gaitC F O'Brien
Seminars in Neurology|September 1, 1995
Involuntary movement disorders following lightning and electrical injuriesC F O'Brien
Neurology|June 20, 1998
Extending levodopa action: COMT inhibitionP Martínez-Martín, C F O'Brien
Archives of Neurology|September 1, 1991
N-methyl-D-aspartate antagonists in the treatment of Parkinson's diseaseJ T Greenamyre, C F O'Brien
Muscle & Nerve. Supplement|January 1, 1997
A clinical overview of treatment decisions in the management of spasticityM E Gormley, C F O'Brien, S A Yablon
Drugs & Aging|November 1, 1996
Spasticity after stroke. Epidemiology and optimal treatmentC F O'Brien, L C Seeberger, D B Smith
Neuroscience Letters|October 28, 1991
Heterogeneous dopamine receptor changes in early and late Huntington's diseaseE K Richfield, C F O'Brien, T Eskin, et al.
Neurorehabilitation and Neural Repair|August 31, 2001
The estimated cost of managing focal spasticity: a physician practice patterns surveyP W Radensky, J W Archer, S F Dournaux, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study)D D Truong, P A Cullis, C F O'Brien, et al.
Pageof 2